OpenVSafe by OpenVAERS
Search V-safe

9EA-29078-79108

1 vaccination 3 coded responses 4 check-ins 3 free-text entries 1 call case
Sex
Male
Age at first dose
26-30
ZIP prefix
201 / VA
Registered
2021-05-06
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-20
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-06
    Registered in v-safe
  3. 2021-05-06
    Survey response — day 42, dose 1
    MedDRA: Emergency care, Petechiae — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Presented to ER on 3/22 with petechiae rash. Had blood tests done, blood work came back normal and was discharged. Initial petechiae faded but then would reappear elsewhere on my body intermittently. Arms, chest, stomach, legs, feet.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-05-06
    Report sent to call center — day 42, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  5. 2021-06-19
    Survey response — 3 months, dose 1
    MedDRA: Petechiae — Feeling: Fair
    Free text: Continuous petechiae spots. Still being investigated
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-09-18
    Health check-in — 6 months, dose 1
    Feeling: Fair
    Adult check-in
  7. 2022-01-07
    Call successful
    Does not wish to fill out VAERS report
  8. 2022-03-20
    Survey response — 12 months, dose 1
    MedDRA: Deep vein thrombosis, Petechiae — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: I am a trans woman who started hormones in December via estradiol injections IM. I was diagnosed with a right lower leg DVT on 1/22. I've had petechiae on my feet since I got vaccinated in March of 2021. I think it's related.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-20Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 8 — day 42, dose 1

2021-05-06

Symptoms: Presented to ER on 3/22 with petechiae rash. Had blood tests done, blood work came back normal and was discharged. Initial petechiae faded but then would reappear elsewhere on my body intermittently. Arms, chest, stomach, legs, feet.

Release 9 — 3 months, dose 1

2021-06-19

Symptoms: Continuous petechiae spots. Still being investigated

Release 11 — 12 months, dose 1

2022-03-20

Symptoms: I am a trans woman who started hormones in December via estradiol injections IM. I was diagnosed with a right lower leg DVT on 1/22. I've had petechiae on my feet since I got vaccinated in March of 2021. I think it's related.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDeep vein thrombosis · · ✓
SDEmergency care ✓ ✓ ✓
SDPetechiae ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release